跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle - TGA Drug Approval Details
Approvals
/
TGA
/
Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle
Approved
STANDARD
Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
4c2bcdfd32fab235
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
4c2bcdfd32fab235
Product Name
Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle
Artg Id
401190
Artg Name
Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2022-12-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
4c2bcdfd32fab235
Type
Standard
Back to TGA Approvals
